DelveInsight's Acute on Chronic Liver Failure Market Insights report includes a comprehensive understanding of current ...
Gedeptin is a non-replicating adenoviral vector delivering the E. coli purine nucleoside phosphorylase (PNP) gene directly into tumor tissue. Following intratumoral injection, patients receive ...
Eczema, a chronic inflammatory skin condition, significantly impacts patients’ quality of life through persistent itching and ...
Interim data from Wave Life Sciences' INLIGHT trial showed promising results for WVE-007, an investigational treatment for obesity.
Galmed Pharmaceuticals ( ($GLMD) ) has provided an update. On December 8, 2025, Galmed Pharmaceuticals announced the acceptance of a late-breaking ...
This study retrospectively analyzed ten pediatric patients with HOX-driven AML who received revumenib maintenance after HSCT at a single-center. The median age was 10 years (range: 1-18). 80% (8/10) ...
The poster presentation, titled “COMBAT-ALS Phase 2b/3 Trial of MN-166 (Ibudilast) in ALS: Trial Update and Basic Characteristics” (Reference # CTL-21), highlighted the following: Overview of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback